Latest Blog Posts Tagged "Research News"
November 23, 2015
The new MDS Clinical Diagnostic Criteria for Parkinson's Disease reflects our updated understanding of, for example, genetics and non-motor symptoms.
October 20, 2015
A research study reports improved symptoms and impact on Parkinson's disease biology with a cancer drug. See what an MJFF Scientific Advisory Board member has to say about these results.
October 02, 2015
Test your knowledge of promising treatments.
September 29, 2015
A recent paper from The University of Michigan shows that more everyday physical activity, perhaps more so than vigorous exercise, is associated with less severe motor symptoms.
September 24, 2015
MJFF-funded researchers announced the first U.S. patients have received focused ultrasound for dyskinesia with PD, providing more information about this alternative approach to managing disease.
September 08, 2015
Using data from the MJFF-led Parkinson's Progression Markers Initiative, NIH researchers have identified five criteria that together may be able to predict who will develop Parkinson's disease.
September 04, 2015
Acadia Pharmaceuticals announced this week that it has submitted a New Drug Application to the FDA seeking approval for its drug to treat psychosis associated with Parkinson's disease.
September 01, 2015
Based on findings from MJFF-funded research, today the Parkinson Study Group announced an NIH grant for a Phase III trial of inosine, a potential disease-modifying treatment for Parkinson's disease.
August 14, 2015
Neuropore Therapies and Biogen grow the field of clinical trials with approaches against alpha-synuclein, our most promising target for a therapy to slow or stop Parkinson's progression.
July 29, 2015
Drugs in development that go after the processes, rather than the proteins, involved in Alzheimer's onset may have potential to treat Parkinson's disease, as well.